Register entry
- Registered sites
- 0
- Active NDC listings
- 31
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3131 active NDC listings: 23 drug for further processing, 8 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 23, BULK INGREDIENT 8.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 19 |
| powder | 8 |
| spray, metered | 2 |
| cream | 1 |
| tablet, for suspension | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| glaxo operations uk ltd | 31 |
Catalogue
Marketed products
31| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Daprodustat | tablet, film coated | 63379-106DRUG FOR FURTHER PROCESSING |
| - | Daprodustat | tablet, film coated | 63379-107DRUG FOR FURTHER PROCESSING |
| - | Daprodustat | tablet, film coated | 63379-108DRUG FOR FURTHER PROCESSING |
| - | Daprodustat | tablet, film coated | 63379-109DRUG FOR FURTHER PROCESSING |
| - | Daprodustat | tablet, film coated | 63379-110DRUG FOR FURTHER PROCESSING |
| - | Linerixibat | tablet, film coated | 63379-119DRUG FOR FURTHER PROCESSING |
| - | abacavir sulfate | powder | 63379-049BULK INGREDIENT |
| - | abacavir sulfate | tablet, film coated | 63379-095DRUG FOR FURTHER PROCESSING |
| - | abacavir sulfate and lamivudine | tablet, film coated | 63379-094DRUG FOR FURTHER PROCESSING |
| - | abacavir sulfate, doluteravir sodium, lamivudine | tablet, film coated | 63379-092DRUG FOR FURTHER PROCESSING |
| - | cabotegravir sodium | tablet, film coated | 63379-079DRUG FOR FURTHER PROCESSING |
| - | docosanol | cream | 63379-085DRUG FOR FURTHER PROCESSING |
| - | dolutegravir sodium | tablet, film coated | 63379-062DRUG FOR FURTHER PROCESSING |
| - | dolutegravir sodium | tablet, film coated | 63379-063DRUG FOR FURTHER PROCESSING |
| - | dolutegravir sodium | tablet, film coated | 63379-067DRUG FOR FURTHER PROCESSING |
| - | dolutegravir sodium | tablet, for suspension | 63379-077DRUG FOR FURTHER PROCESSING |
| - | dolutegravir sodium and rilpivirine hydrochloride | tablet, film coated | 63379-072DRUG FOR FURTHER PROCESSING |
| - | dutasteride | powder | 63379-016BULK INGREDIENT |
| - | eltrombopag olamine | tablet, film coated | 63379-089DRUG FOR FURTHER PROCESSING |
| - | eltrombopag olamine | tablet, film coated | 63379-090DRUG FOR FURTHER PROCESSING |
| - | fluticasone furoate | spray, metered | 63379-083DRUG FOR FURTHER PROCESSING |
| - | fluticasone furoate | spray, metered | 63379-084DRUG FOR FURTHER PROCESSING |
| - | fluticasone furoate | powder | 63379-112BULK INGREDIENT |
| - | fluticasone propionate | powder | 63379-001BULK INGREDIENT |
| - | fosamprenavir calcium | tablet, film coated | 63379-087DRUG FOR FURTHER PROCESSING |
| - | labivudine and zidovudine | tablet, film coated | 63379-086DRUG FOR FURTHER PROCESSING |
| - | pazopanib hydrochloride | tablet, film coated | 63379-093DRUG FOR FURTHER PROCESSING |
| - | salbutamol sulphate | powder | 63379-007BULK INGREDIENT |
| - | umeclidinium bromide | powder | 63379-113BULK INGREDIENT |
| - | vilanterol trifenatate | powder | 63379-114BULK INGREDIENT |
| - | zanamivir | powder | 63379-028BULK INGREDIENT |
Compare
Other companies listing daprodustat
- Glaxo Wellcome Manufacturing Pte. Ltd0 sites · 13 NDC
Enquiry
Common questions
- Is Glaxo Operations UK Ltd FDA approved?
- Glaxo Operations UK Ltd holds no registered establishment of its own; 31 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Glaxo Operations UK Ltd make?
- 31 products are listed under Glaxo Operations UK Ltd in the openFDA NDC Directory, most often as tablet, film coated; powder; spray, metered. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.